78 filings
Page 4 of 4
8-K
7w7yvr
29 Jul 19
Regulation FD Disclosure
4:40pm
8-K
btdleo5c55szf3 oaad
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
8-K
wzfx446q
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm
8-K
gsoaeo
21 Jun 19
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
7eo30
23 May 19
Departure of Directors or Certain Officers
4:01pm
8-K
syy2 dal6
3 May 19
Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
5:08pm
8-K
59njs
28 Mar 19
Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
4:00pm
8-K
mod76ku
8 Mar 19
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:04pm
8-K
g8cp6u5l
8 Jan 19
Regulation FD Disclosure
12:00am
8-K
2psivkect sk
9 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:14pm
8-K
0xus4nw9
9 Nov 18
Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
12:40pm
8-K
4ld0xp0a
9 Aug 18
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:07pm
8-K
s3jzp6lm
11 Jun 18
Submission of Matters to a Vote of Security Holders
4:48pm
8-K
fjuv6tq3
14 May 18
Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
4:01pm
8-K
nt9izjhus
2 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
dz4gnp6qx5our8e9w mu
14 Mar 18
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
fjmkaf6dsfi q9
1 Nov 17
Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of
12:00am
8-K
8v67pfhvr boygons62s
10 Oct 17
Rhythm Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
12:00am